Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Benchmark Genetics Norway AS
AS
Active
Org 983506925
Bradbenken 1, 5003
Bergen
Support activities for fishing and aquaculture
·
NACE 0330
Est. 2001 · 24 years old
89 employees
www.bmkgenetics.com
Monitor
Share
Norway
/
Companies
/
Support activities for fishing and aquaculture
/
Benchmark Genetics Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
517M
388M
258M
129M
0M
2020: 240M
240M
2020
2021: 291M (+21% vs 2020)
291M
+21%
2021
2022: 356M (+22% vs 2021)
356M
+22%
2022
2023: 415M (+17% vs 2022)
415M
+17%
2023
2024: 336M (-19% vs 2023)
336M
-19%
2024
EBITDA
NOK millions
71M
53M
35M
18M
0M
2020: 28M
28M
2020
2021: 24M (-14% vs 2020)
24M
-14%
2021
2022: 46M (+92% vs 2021)
46M
+92%
2022
2023: 57M (+24% vs 2022)
57M
+24%
2023
2024: 45M (-21% vs 2023)
45M
-21%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
335 867
414 588
355 834
291 449
240 283
Staff expenses
−51 659
−53 248
−46 097
−41 054
−35 803
EBITDA
44 686
57 033
45 571
23 601
28 461
Depreciation & amort.
−3 885
−2 878
−2 747
−2 714
−2 388
EBIT
40 801
54 156
42 824
20 887
26 073
Net financials
5 082
−32
−2 114
−1 466
−4 881
Profit before tax
45 883
54 123
40 710
19 421
21 192
Tax
9 947
12 009
8 629
3 879
4 119
Net profit
35 936
42 115
32 080
15 542
17 074
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
295 382
321 814
326 171
327 271
299 659
Equity
192 175
156 239
114 124
82 044
66 502
Long-term debt
14 546
66 081
130 373
188 131
187 892
Short-term debt
88 661
99 494
81 674
57 096
45 265
Total debt
103 207
165 575
212 047
245 227
233 157
Financial ratios
5-year trend
EBITDA margin
13,3 %
This company
15,8 %
Market median
This company
Market median
16% below market
2020
2024
Equity ratio
65,1 %
This company
38,2 %
Market median
This company
Market median
70% above market
2020
2024
Return on equity
18,7 %
This company
18,4 %
Market median
This company
Market median
2% above market
2020
2024
Net profit margin
10,7 %
This company
8,1 %
Market median
This company
Market median
32% above market
2020
2024
Asset turnover
1,14×
This company
1,12×
Market median
This company
Market median
2% above market
2020
2024
Debt / equity
0,54×
This company
0,62×
Market median
This company
Market median
13% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-10-01 – 2021-09-30
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2019-10-01 – 2020-09-30
View
PDF
More on Benchmark Genetics Norway AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
